Patna, 800020,
India
Acme Therapeutics India Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Acme Therapeutics India and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 100 Acme Therapeutics India employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Acme Therapeutics India has purchased the following applications: DOSarrest for DDoS Protection in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Acme Therapeutics India is running and its propensity to invest more and deepen its relationship with Link11 or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Acme Therapeutics India revenues, which have grown to $5.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Acme Therapeutics India intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
CyberSecurity
Vendor |
Old Product |
New Product |
Category |
Market |
VAR/SI |
When |
Live |
|---|---|---|---|---|---|---|---|
| Link11 | Legacy | DOSarrest | DDoS Protection | CyberSecurity | n/a | 2022 | 2022 |
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||